Search Results (120)

Introduction: Recent advancements in technologies, such as 3D printing, have been adopted in prosthodontics to streamline clinical procedures and provide high-quality prosthetic devices to patients within a reduced timeframe. Aim of the study: This study primarily aimed to determine the color change levels of 3D-printed dental resins for temporary and long-term intraoral applications. We also evaluated the effectiveness of post-processing procedures such as polishing or glazing on color stability. Materials and methods: Three types of dental resins were tested in distilled water, coffee, and wine environments for 2, 7, 30, and 60 days. A spectrophotometric analysis was conducted, and the Ciede2000 formula was used to determine the DE. Results: The material type, conditioning method, and storage time significantly affected the color changes of the tested materials. The post-processing technique had the most remarkable impact on color stability over time. Conclusions: Glazing of the 3D-printed material surface appears to be the most effective approach to prolong its clinical applicability by maintaining color stability. Full article

The aim of this study was to investigate which physicochemical and structural properties of cationic peptides P1–P6 may determine their selective anticancer activity against melanoma cells and their interactions with tumor cell membranes. An integrated approach was applied, including characterization in solution (osmotic pressure, NaCl stability, surface tension); cytotoxicity evaluation against Me45, B16F10, and HaCaT cells; analysis of interactions with phosphatidylglycerol (POPG) model membranes using isothermal titration calorimetry and steady-state fluorescence spectroscopy; membrane permeability assays; and F-actin staining. Anticancer activity depended on positively charged residues, hydrophobic amino acids, and sequence arrangement. Tryptophan-rich peptides P2 and P5 exhibited strong membrane interactions and high efficacy after 72 h. Highly hydrophobic P4, containing long C₁₂ chains with a relatively low net charge, caused nonselective lysis. P3 showed reduced activity due to insufficient amphipathicity, whereas P6, with excessive WWW and KKKK motifs, exhibited weak or nonselective effects. Thermodynamic and fluorescence analyses indicated that P2 and P5 initially bind POPG membranes via entropy-driven electrostatic interactions, followed by hydrophobic insertion of tryptophan residues, evidenced by increased fluorescence intensity and a blue shift of the emission maximum. P2, P4, and P5 induced actin cytoskeleton reorganization and increased membrane permeability, emphasizing the role of balanced amphipathicity and charge–hydrophobicity in designing selective anticancer peptides. Full article

The global energy crisis driven by an 80% reliance on fossil fuels and the urgent need to reduce greenhouse gas emissions demands the exploration of sustainable biotechnological alternatives. This study addresses a critical knowledge gap regarding the integration of fungal secondary metabolites into bioelectrochemical energy systems, as these compounds have traditionally been investigated for pharmacological purposes. The methodology involved a documentary analysis using the Scopus database (2000–2025), applying a search equation that combined terms such as “secondary metabolite”, “fungi”, and “bioenergy”. Data processing was conducted using R Studio (R 3.6.0+), VOSviewer (1.6.20) for collaboration networks, and Plotly Studio (v6.5.0) for interactive visualizations. Key findings revealed that redox mediators such as quinones and organic acids derived from Aspergillus niger enhanced electron transfer efficiency by 35%, achieving power densities of 1.2 W/m². Meanwhile, Penicillium chrysogenum reduced internal electrode resistance by 40%. Additionally, the “xeno-fungosphere” system achieved 97.9% herbicide removal and generated 9.3 µW/cm². Notably, biosynthesized bis-quinones were successfully applied in redox flow batteries, reaching a capacity of 1.58 Ah/L. In conclusion, the study identified a scientific shift from pharmacological applications toward energy metabolism and sustainability, positioning fungi as critical components for the future efficiency of bioelectrical technologies. Full article

Polymers and their composites have introduced significant advancements in engineering and technology. The primary advantages of polymeric materials include their lightweight nature, ease of manufacturing, anti-corrosion properties, reduced power consumption during assembly and integration, as well as enhanced stiffness, durability, and fatigue resistance. Polymer coatings with conductive polymers allow efficient charge transfer and make electrodes more flexible, helping them better match the mechanical properties of soft tissues. In addition, polymer coatings can protect electrodes from corrosion, reduce biofouling, and provide sites for attaching biomolecules, making them essential for reliable and long-term bioelectrode and biosensor performance. Polymer coatings for electrochemical bioelectrodes play a crucial role in enhancing sensor performance and stability in biological environments as they improve the interaction between electronic devices and biological tissues. These coatings enhance biocompatibility by reducing inflammation and tissue damage while also lowering electrode impedance to improve signal quality. The present review focuses on the most recent developments in polymer coatings for electrochemical biosensors and respective applications. The manuscript provides an overview of polymer materials, emerging strategies, coating approaches, and the resulting enhancements in bioelectrochemical applications. Full article

This systematic review investigates the impact of chronic stress on treatment outcomes among cancer patients with divergent survival rates, focusing on breast, prostate, pancreatic, and ovarian cancers. The analysis explores how chronic stress influences molecular pathways and tumor progression while comparing cancers with five-year survival rates above and below 50%. A comprehensive literature search was conducted in PubMed and Scopus for studies published between 2014 and 2025 using combinations of keywords related to “chronic stress,” “psychological stress,” “psychotherapy,” and selected cancer types. All studies met the inclusion criteria according to the PRISMA 2020 guidelines. Evidence suggests that chronic stress is associated with the activation of neuroendocrine and immune mechanisms, including β-adrenergic and glucocorticoid signaling. These multifactorial processes are associated with disease progression and survival, particularly in pancreatic and ovarian cancers; however, these links remain primarily associative rather than causative. Conversely, psychotherapeutic interventions alleviate stress-related biological responses, improve quality of life, and may indirectly enhance therapeutic efficacy. By structuring the evidence around cancers with higher versus lower five-year survival, our review provides a survival informed synthesis of cancer type specific stress biology and stress-mitigating interventions, highlighting potentially targetable pathways and clear evidence gaps for future trials. The findings underscore the need to integrate psychological care into oncological practice to improve overall outcomes. Full article

Global dependence on fossil fuels generates severe environmental and socioeconomic impacts, driving the urgent search for sustainable energy alternatives. In response to this global challenge, this research conducts a bibliometric analysis of hydrogen production via biohybrid systems, using publications indexed in Scopus from 2005 to 2025 and analyzed with VOSviewer. The results revealed a significant increase in research output since 2015, driven primarily by interdisciplinary developments in biotechnology, nanotechnology, and bioelectrochemistry, as well as by international sustainability policies. Four main research approaches were identified: bio-assisted photocatalysis, bio-electrochemical systems, dark fermentation, and enhanced artificial photosynthesis with nanomaterials. Despite the progress achieved, significant limitations remain in energy efficiency, operational costs, and the oxygen sensitivity of key enzymes. The study emphasizes that interdisciplinary collaboration is crucial to overcoming these barriers, highlighting priority areas for future research to strengthen the potential of biohybrid hydrogen as a viable and sustainable solution in the global energy transition. Full article

Electroporation can be used as an effective non-viral gene delivery method, while the application of conductive nanoparticles (NPs) with pulsed electric fields (PEFs) may increase treatment efficacy due to local field amplification in close proximity to the cell plasma membrane. In this work, we have employed 100 ns and 300 ns pulses (9–17 kV/cm), which were delivered in bursts (n = 100) and predefined inter-pulse delays (100–900 ns), which enabled successful gene delivery (4.7 kbp; p-EGFP-N1) using pulses as short as 100 ns, which previously was considered impossible. As a model, a murine breast cancer cell line (4T1) was used. It was shown that sub-microsecond pulses (i.e., 300 ns) can be effective for gene delivery, whereas 100 ns pulses are several-fold inferior, yet still trigger successful gene transfer (>10% of cells being electrotransfected). In order to increase the efficacy of the treatment, we used gold nanoparticles (AuNPs; the diameter of 13 nm), which allowed us to achieve electrotransfection efficacy several-fold for both sub-microsecond and microsecond protocols (1.2 kV/cm × 100 µs × 8 pulses at 1 Hz). The results suggest high potential applicability of conductive nanoparticles in future translational or clinical research involving electroporation and gene transfer. Full article

Organ fibrosis is a progressive and often irreversible pathological process characterized by excessive deposition of extracellular matrix, leading to tissue dysfunction and failure. Despite its significant impact on various organ systems, available antifibrotic therapies remain limited. This review focuses on novel therapeutic approaches to inhibit fibrosis and improve clinical outcomes. Current strategies include small molecule inhibitors, monoclonal antibodies targeting fibrosis mediators, gene therapies, and cell-based approaches, including mesenchymal stem cells and induced pluripotent stem cells. In addition, the development of innovative drug delivery systems and combination therapies involving pulsed magnetic fields (PMFs) opens new possibilities for increasing the precision and efficacy of treatment. In recent years, multiomic approaches have enabled a better understanding of fibrosis mechanisms, facilitating the personalization of therapy. The role of artificial intelligence in drug discovery has also increased, as exemplified by models that support the design of small-molecule inhibitors currently undergoing clinical evaluation. This review discusses key signaling pathways involved in fibrosis progression, such as TGF-β, p38 MAPK, and fibroblast activation, as well as novel therapeutic targets. Although clinical trial results indicate promising potential for new therapies, challenges remain in optimizing drug delivery, considering patient heterogeneity, and ensuring long-term safety. The future of fibrosis therapy relies on integrating precision medicine, combination therapies, and molecularly targeted strategies to inhibit or even reverse the fibrosis process. Further intensive interdisciplinary collaboration is required to successfully implement these innovative solutions in clinical practice. Full article

This bibliometric study analyzes the evolution of biomaterials used for electrodes in microbial fuel cells (MFCs), highlighting a marked increase in publications since 2019. Key materials—including modified cellulose, lignin, and carbon nanocomposites—have improved electrode efficiency and structural stability. The findings indicate that high-impact journals, such as the Journal of Microbial Fuel Cell Research and Bioelectrochemistry & Sustainable Energy (with h-indices of 72 and 64, respectively), have played a pivotal role in advancing the field. Prominent researchers, including Yang J and Xie Q, have made significant contributions, as reflected in their high citation counts. Network analysis reveals limited international collaboration, underscoring the need to strengthen strategic partnerships. Ultimately, this study highlights the importance of future research that integrates artificial intelligence and nanotechnology to optimize biomaterial performance in MFCs, thereby enhancing their contribution to sustainable energy solutions. Full article

The hitherto unknown thiol-disulfide redox potential (E₀′) of the β93Cys residue in the HbS (β^6Glu→Val) variant of human hemoglobin was calculated by MALDI-ToF mass spectrometry, which analyzes blood from a heterozygous carrier. To calculate the (E₀′) value, a redox equilibrium model was adopted, and the previously calculated value for wild-type β-Hb chain (E₀′ −121 mV) was used. An E₀′ value of −130.5 ± 1.7 mV for the β93Cys residue of HbS was obtained, thus a more reducing value than E₀′ in the wild-type isoform. Glutathionylation from this residue in the HbS tetramer lowers the extent of protein aggregation in fibrils and the clinical consequences, such as painful capillary occlusion and hemolysis. This finding confirmed the peculiar property of HbS as a more reactive scavenger of glutathione sulphinic acid (E₀′ = −264 mV), which forms in the cytoplasm of red blood cells and reacts with structural and regulatory proteins, including hemoglobin. The ability to assess the erythrocyte oxidative status in sickle cell carriers can be developed into an additional functional test to rationally assess the effect of drug treatment and antioxidant dietary interventions on improving disease control. Full article

Herbs from the Gentianaceae family are widely known for their medicinal and pharmacological properties. They were used centuries ago as a part of traditional medicine in China and Tibet. This review aims to draw attention to the potential uses of gentian herbs in treating various diseases, including skin conditions, gastrointestinal and liver disorders, wound healing, rheumatoid arthritis, and diabetes. The aim of our study was to systematically summarize current knowledge about key bioactive compounds present in both roots and aerial parts—such as xanthones, iridoids, and flavonoids—and highlight their pharmacological significance. We also focused on the Gentianaceae family’s usage in complementary and alternative medicine, as well as their anti-inflammatory, anti-melanogenic, anti-ischemic, anti-fibrotic, and antioxidant properties, which can be utilized in the treatment and prevention of dermatological diseases, such as skin cancers. Here, we involve ethnomedicinal knowledge with modern pharmacological data; we also highlight the scientific relevance of gentian-derived compounds in drug development. This review concludes that these species represent a promising source of natural agents, while also underlining the need for further research and conservation strategies to preserve threatened species. Full article

Mucinous ovarian carcinoma (MOC) represents a rare and biologically distinct subtype of ovarian cancer, characterized by poor response to standard platinum-based chemotherapy and a unique molecular profile, including frequent KRAS mutations and HER2 amplifications. Recent advancements in targeted therapy, such as HER2 inhibitors and KRAS^G12C inhibitors, offer promising avenues for personalized treatment. Immunotherapy, particularly checkpoint inhibitors, shows potential in tumors with high PD-L1 expression or tumor mutational burden. Novel strategies, including antibody–drug conjugates, synthetic lethality approaches, and Wnt/β-catenin pathway inhibitors, are reshaping the therapeutic landscape. Despite these developments, challenges such as intratumoral heterogeneity and therapy resistance persist, underscoring the need for innovative clinical trial designs and combination regimens. This review synthesizes the latest advancements in MOC therapies, highlighting opportunities for improved outcomes in this challenging malignancy. Full article

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterized by intense pruritus and a significant impact on a patient’s quality of life. Despite advancements in understanding AD pathophysiology, there remains a critical need for innovative therapeutic options to better manage this debilitating disease. This review focuses on the evolving landscape of biological therapies for AD, offering insights into their role, mechanisms of action, and potential to revolutionize patient care. In this review, we explore the underlying immunological mechanisms of AD, particularly the role of cytokines and immune pathways implicated in the disease, and how targeted biological therapies modulate these pathways. Current FDA- and EMA-approved biologics, such as Dupilumab, are also discussed in terms of their mechanisms of action, efficacy, and safety. Additionally, we compare their effectiveness, highlighting the benefits and limitations observed in clinical practice. Emerging biological therapies currently under development offer new hope, with innovative targets like IL-13, IL-31, and thymic stromal lymphopoietin (TSLP) representing promising avenues for intervention. We also delve into personalized medicine, emphasizing the importance of biomarkers for predicting treatment response and stratifying AD patients to optimize therapeutic outcomes. Moreover, the synergistic potential of combining biologics with traditional therapies is reviewed, along with a discussion of the challenges involved, including safety, long-term efficacy, and patient adherence. We address the future direction of AD treatment, including microbiome-targeting biologics and the development of next-generation immune modulators. We highlight a new era of targeted treatment possibilities for this complex condition. Full article

Telomeres are repetitive DNA sequences at the ends of chromosomes that protect against genomic instability and prevent unwanted DNA damage responses. In most somatic cells, telomeres progressively shorten with each division, limiting cellular lifespan. However, cancer cells bypass this limitation by activating telomerase or the alternative lengthening of telomeres, enabling unchecked proliferation and tumor progression. This review examines the molecular mechanisms underlying telomere maintenance and their intricate relationship with DNA repair pathways. We discuss how telomere-associated proteins regulate genomic stability and explore therapeutic strategies targeting telomerase and alternative lengthening of telomeres. Challenges such as resistance mechanisms and off-target effects are also considered, highlighting the need for precision approaches in telomere-based cancer therapies. Full article